Adult Hepatocellular Carcinoma Completed Phase 1 Trials for Cixutumumab (DB12250)

Also known as: Hepatocellular Carcinoma, Adult / Adult hepatocellular carcinoma (disorder)

IndicationStatusPhase
DBCOND0040123 (Adult Hepatocellular Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01008566Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerTreatment